The role of MASTL in promoting colon cancer is supported by our findings that its expression is markedly increased in colon cancer cells, in transcriptome and protein expression analyses of a large CRC patient cohort, in the cancer genomic atlas (TCGA) database, and in colon tumors that result from mouse model of sporadic or inflammation-induced colon cancer. Here, MASTL is linked to malignant colon neoplasm.